Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Public ClinicalTrials.gov record NCT03113825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Study identification
- NCT ID
- NCT03113825
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Avelas Biosciences, Inc.
- Industry
- Enrollment
- 92 participants
Conditions and interventions
Conditions
Interventions
- AVB-620 Drug
- Investigational Imaging device Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 4, 2017
- Primary completion
- Apr 7, 2020
- Completion
- Nov 17, 2020
- Last update posted
- Jun 10, 2021
2017 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD | San Diego | California | 92093 | — |
| Medstar Washington Hospital | Washington D.C. | District of Columbia | 200010 | — |
| Mayo Clinic Jacksonville -- Center for Breast Health | Jacksonville | Florida | 32224 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Advocate Good Shepherd Hospital | Barrington | Illinois | 60010 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| UNLV School of Medicine | Las Vegas | Nevada | 89102 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Montefiore Einstein Center for Cancer Care | The Bronx | New York | 10461 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Ohio State University, James Cancer Center | Columbus | Ohio | 43210 | — |
| Roper St. Francis Hospital | Charleston | South Carolina | 29401 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03113825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2021 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03113825 live on ClinicalTrials.gov.